Developmental Pharmacology and Therapeutics · 2017 · 44 citations · 0 references
PharmacyHuman DevelopmentToxicologyDevelopmental ToxicologyMaternal-fetal MedicineReproductive ToxicologyCannabinoid ToxicologyDevelopmental ToxicityIntrauterine Growth RestrictionPregnancyPrenatal DevelopmentPrenatal ToxicologyCannabinoid TeratogenicityCannabis Reproductive ToxicologyExperimental StudiesIntrauterine Growth RetardationOffspring GrowthPrenatal Cannabis ExposurePrenatal Drug ExposurePrenatal Substance Exposure
5 newborn infants, whose mothers acknowledged steady use of marihuana prior to and during pregnancies, displayed symptoms of intrauterine growth retardation, neurological problems, and abnormal morphogenesis. These findings fit in with the experimental studies and surveys of pregnant human populations which have indicated that cannabis products have teratogenic potential, though rigorous proof must await further information.